0001437749-19-007471.txt : 20190417 0001437749-19-007471.hdr.sgml : 20190417 20190417201654 ACCESSION NUMBER: 0001437749-19-007471 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190415 FILED AS OF DATE: 20190417 DATE AS OF CHANGE: 20190417 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schick Joseph C CENTRAL INDEX KEY: 0001592238 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36362 FILM NUMBER: 19754241 MAIL ADDRESS: STREET 1: 16719 NE 139TH PLACE CITY: WOODINVILLE STATE: WA ZIP: 98072 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC CENTRAL INDEX KEY: 0000834365 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943076866 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4254011400 MAIL ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: BIOLIFE SOLUTION INC DATE OF NAME CHANGE: 20030113 FORMER COMPANY: FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC DATE OF NAME CHANGE: 19920703 4 1 rdgdoc.xml FORM 4 X0306 4 2019-04-15 0000834365 BIOLIFE SOLUTIONS INC BLFS 0001592238 Schick Joseph C C/O BIOLIFE SOLUTIONS, INC. 3303 MONTE VILLA PARKWAY, SUITE 310 BOTHELL WA 98021 1 Common Stock 2019-04-15 4 M 0 8928 8.51 A 18928 D Common Stock 2019-04-15 4 M 0 10000 2.06 A 28928 D Common Stock 2019-04-15 4 S 0 18928 17.05 D 10000 D Common Stock 2019-04-16 4 S 0 3125 17.47 D 6875 D Employee Stock Option 8.51 2019-04-15 4 M 0 8928 0 D 2014-12-17 2023-12-17 Common Stock 8928 0 D Employee Stock Option 2.06 2019-04-15 4 M 0 10000 0 D 2016-05-04 2025-05-04 Common Stock 10000 5000 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.90 to $17.56, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. /s/ Joseph C. Schick 2019-04-17